Contact Us

Connecticut Office
88 Post Road W
Westport, CT 06880
Tel: 203.210.2000
Google Maps

St. Louis Office
393 N. Euclid
Unit 220 D&G
St. Louis, MO 63108
Google Maps

Boca Raton Office HQ
150 East Palmetto Park Road
Suite 110
Boca Raton, FL 33432
Tel: 561.994.1191
Trading: 561.998.5489
FAX: 561.516.7491
Google Maps

New York Office
The Chrysler Building, 405 Lexington Ave.,
7th Floor
New York, NY 10174
Tel: (212) 863-3227
Google Maps

Noble Management Team

Nico P. Pronk

CEO / President

Department:
Management

E: npronk@noblecapitalmarkets.com
T: (561) 998-5476
VCard: Nico P. Pronk

Mr. Pronk joined NOBLE Capital Markets in 1988 as Chief Operating Officer. In 1995, he became owner. Mr. Pronk began his career in Europe in 1986 on the European Options Exchange (EOE). Mr. Pronk has over 25 years of experience working with IPOs, Secondary Offerings, Private Placements and Mergers and Acquisitions. During his career he has served as Director or Advisor to numerous privately held and publicly traded companies. Mr. Pronk is a graduate of the Netherlands Institute of Banking and Finance, and holds various FINRA licenses. Mr. Pronk is the current Chairman, and principal owner of Privaira, a Boca Raton based private aviation company.

Nico P. Pronk, CEO / President

Mark Pinvidic

Managing Partner

Department:
Management

E: mpinvidic@noblecapitalmarkets.com
T: (561) 994-5742
VCard: Mark Pinvidic

Mr. Pinvidic joined NOBLE Capital Markets in 2002 bringing more than 25 years of senior management experience in corporate communications, marketing, sales and product development across several business sectors including oil & gas, healthcare / biotechnology, retail and consumer goods manufacturing. Throughout his career he has co-founded two public companies and created a consumer products company that, in 1999, was recognized by Women's Wear Daily as developing the most innovative and successful product launch of that year. Mr. Pinvidic has also been recognized by organizations such as the International Association of Business Communicators (IABC), the International Package Design Awards (IPDA), the Design Council of Canada, and the Toronto Art Director's Association for his work on annual reports, corporate identity programs, packaging design and consumer advertising. Mr. Pinvidic is responsible for all aspects of corporate identity, marketing and the management of the various conferences sponsored by NOBLE Capital Markets.

Mark Pinvidic, Managing Partner

Michael Kupinski

Director of Research, Senior Media & Entertainment Analyst

Department:
Management
Media and Entertainment

E: mkupinski@noblecapitalmarkets.com
T: (561) 994-5734
VCard: Michael Kupinski

Michael Kupinski joined Noble Financial in 2007 as director of research and Media & Entertainment senior research analyst. Before joining the company, he was the vice president and Media & Entertainment analyst for A.G. Edwards for twenty-three years. He is a member of the National Cable Television Society Foundation and the National Association of Broadcasters. He was a columnist for the Pulse of Radio, a broadcast radio trade publication, and a trustee of the National Television Academy. The Wall Street Journal selected Mr. Kupinski as a 'Best on the Street' All-Star Analyst in 1996, 1997, 1999, 2001, 2003, and in 2004 for his stock picking skills. Mr. Kupinski is widely quoted in national publications such as USA Today, The Wall Street Journal, and The New York Times, and is a frequent guest on cable news networks CNBC, CNN, and Bloomberg TV.

Michael Kupinski, Director of Research, Senior Media & Entertainment Analyst

Nathan Cali

Managing Director, Head of Healthcare Investment and Merchant Banking

Department:
Investment Banking
Healthcare

E: ncali@noblelsp.com
T: (561) 994-5723
VCard: Nathan Cali

Nathan Cali has more than 14 years of combined healthcare, biotechnology and pharmaceutical experience. Mr. Cali was previously a sell-side analyst for 9 years with expertise and publications cover many areas of biotechnology, specialty pharmaceuticals (branded and generics), medical devices, and regenerative medicine. He has been quoted in most business journals including Reuters, BioMed Reports and the Washington Business Journal. Mr Cali is the co-founder of Variant Pharmaceuticals an early stage biotechnology company advancing orphan drugs for the treatment of renal diseases. He is currently a Committee Member at the Moffitt Cancer Center for Commercialization and a member of the Development Board of Palm Beach County. Mr. Cali started his career in healthcare at Andrx Corporation, a biotechnology and specialty pharmaceuticals company known for its expertise in the development of controlled-release drugs. Mr. Cali was a corporate manager dealing in finance, state taxation, corporate governance, patents, drug distribution and business development for the biotechnology firm. Andrx was purchased by Watson Pharmaceuticals in 2006 for $2.0 billion in cash. Prior to joining NOBLE, Mr. Cali gained investment experience as a portfolio account analyst/manager at Franklin Templeton Investments. Mr. Cali holds a B.S. in Finance from The Florida State University and an M.B.A. in Finance from Nova Southeastern University. Nathan also currently holds series 7, 79, 86, and 87 FINRA designations.

Nathan Cali, Managing Director, Head of Healthcare Investment and Merchant Banking